Sitagliptin Packaging Humidity Control for Nitrosamine Suppression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge is to suppress the production of nitrosamines, specifically 7-Nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo-[4,3-a]pyrazine (NTTP), in sitagliptin preparations, as NTTP is potentially carcinogenic and its acceptable intake is very stringent.
Innovation Solution
A sitagliptin preparation is developed with a packaging system that maintains an equilibrium relative humidity of 0.3% or less for the sitagliptin containing tablet, when stored for one month under conditions of 25°C and 60% relative humidity, using an airtight case or packing with a desiccant to control moisture levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional storage conditions are used, then the sitagliptin preparation is easy to store, but NTTP is produced at levels exceeding acceptable intake limits
Solution Approach 1:
The packaging system is segmented into multiple functional layers: an airtight case providing primary sealing, a desiccant packet for moisture absorption, and specific packaging materials (aluminum foil, plastic resin) that create barrier properties. This segmentation allows each component to address specific aspects of moisture control, collectively suppressing NTTP production while maintaining manageable complexity through modular design
Solution Approach 2:
A desiccant packet is introduced as an intermediary substance between the sitagliptin preparation and the external environment. The desiccant actively absorbs moisture that penetrates the airtight case, maintaining internal humidity at levels that prevent NTTP formation. This intermediary component bridges the gap between conventional storage and the stringent requirements for nitrosamine suppression
2Object-generated harmful factors
If the equilibrium relative humidity is reduced to 0.3% or less, then NTTP production is suppressed, but the storage conditions become more stringent
Solution Approach 1:
The invention changes the humidity parameter from conventional storage levels (typically 5-20% relative humidity) to an extremely low level of 0.3% or less equilibrium relative humidity. This parameter change is achieved through the combined effect of airtight sealing and desiccant placement, transforming the storage environment to suppress NTTP production while the desiccant automatically maintains this precise humidity level without requiring active control systems
Solution Approach 2:
The desiccant packet provides self-service moisture absorption, automatically maintaining the equilibrium relative humidity at 0.3% or less without external intervention. The desiccant continuously absorbs any moisture that enters the airtight case, self-regulating the internal humidity environment to prevent NTTP formation while eliminating the need for complex active humidity control systems
3Object-generated harmful factors
If an airtight case with desiccant is used, then NTTP production is suppressed, but the packaging complexity increases
Solution Approach 1:
A disposable desiccant packet is incorporated into the airtight case, providing effective moisture absorption throughout the product shelf life. The desiccant packet is a low-cost, single-use component that is discarded with the medication packaging, eliminating the need for reusable or regenerable moisture control systems. This approach suppresses NTTP production while keeping the overall packaging complexity and cost manageable through the use of simple, disposable materials
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively suppresses the production of NTTP in sitagliptin preparations to within the daily acceptable intake limit of 37 ng, ensuring safety and compliance with stringent reporting thresholds.
Implementation Method 1
an equilibrium relative humidity of the sitagliptin containing tablet as converted at 24° C. is 0.3% or less when the sitagliptin preparation is stored for one month under a condition of 25° C. and a relative humidity of 60%
Data Source
AI summary
An embodiment of the present invention provides a sitagliptin preparation in which the production of nitrosamines is suppressed. Alternatively, an embodiment of the present invention provides a method of storage of a sitagliptin preparation to suppress the production of nitrosamines. According to an embodiment of the present invention, a sitagliptin preparation is provided comprising a sitagliptin containing tablet, and a case or a packing sealing the sitagliptin containing tablet, wherein an equilibrium relative humidity of the sitagliptin containing tablet as converted at 24° C. is 0.3% or less when the sitagliptin preparation is stored for one month under a condition of 25° C. and a relative humidity of 60%.